Back
ACRES Commercial Realty Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
49
ACR
ACRES Commercial Realty
Last Price:
12.91
Seasonality Move:
-3.99%
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
38.01
Seasonality Move:
3.65%
Sell
49
ACRES Commercial Realty (ACR)
is a Sell
Is ACRES Commercial Realty a Buy, Sell or Hold?
- The current ACRES Commercial Realty [ACR] share price is $12.84. The Score for ACR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- ACR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACR Stock Price Chart
What is ACRES Commercial Realty's stock price today?
-
The ACRES Commercial Realty share price today is $12.84
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACR is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $37.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
ACR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 48.82 | Sell |
Chaikin Money Flow: | 11428 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.57 - 13.13) | Sell |
Bollinger Bands (100): | (10.82 - 13.76) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.58 | Sell |
Relative Strength Index (14 RSI): | 37.74 | Sell |
Chaikin Money Flow: | -836354 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.26 - 42.36) | Sell |
Bollinger Bands (100): | (41.26 - 48.86) | Sell |
ACR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.77 | Buy |
20-day SMA: | 12.75 | Buy |
50-day SMA: | 13.24 | Sell |
200-day SMA: | 10.36 | Buy |
8-day EMA: | 12.78 | Buy |
20-day EMA: | 12.84 | Buy |
50-day EMA: | 12.85 | Sell |
200-day EMA: | 11.18 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.11 | Sell |
20-day SMA: | 40.61 | Sell |
50-day SMA: | 42.43 | Sell |
200-day SMA: | 42.45 | Sell |
8-day EMA: | 40.32 | Sell |
20-day EMA: | 40.92 | Sell |
50-day EMA: | 42.29 | Sell |
200-day EMA: | 43.55 | Sell |
ACRES Commercial Realty Earnings Growth & ACR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.18 per share, and an increase next year of $0.38 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
ACRES Commercial Realty Technical Analysis
Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |